We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 761

OIG Dusts off the Old Rule Book to Say No to Free Expensive Drugs to Hospitals
  • McDermott Will & Emery
  • USA
  • December 10 2018

The Office of Inspector General, Department of Health and Human Services posted an unusual negative Advisory Opinion (AO 18-14) on a drug company’s


Hall Render’s This Week in Washington - December 7, 2018
  • Hall Render Killian Heath & Lyman PC
  • USA
  • December 7 2018

On December 6, Congress passed a continuing resolution that extends current funding for select federal agencies for two weeks. The extension became


HHS OIG Launches Cybersecurity Webpage to Raise Awareness and Boost Cybersecurity Best Practices
  • Baker & Hostetler LLP
  • USA
  • December 5 2018

Healthcare data can be up to 10 times more valuable to cyber criminals than credit card numbers, according to a report from the Department of Health &


Hall Render’s This Week in Washington - November 30, 2018
  • Hall Render Killian Heath & Lyman PC
  • USA
  • November 30 2018

As government funding battles overtake Capitol Hill, it appears Congress will not use the lame duck to resolve outstanding health care issues


Regulatory Insights for Life Sciences and Health Care Investments: Drug Pricing and Reimbursement
  • Hogan Lovells
  • USA
  • November 29 2018

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure


Life Sciences: Compliance and enforcement in the USA
  • DLA Piper
  • USA, Global
  • November 14 2018

A structured guide to compliance and dishonest practices in the USA


Life Sciences: product regulation and liability in the USA
  • DLA Piper
  • USA, Global
  • November 14 2018

A structured guide to product regulation and liability laws in the USA


Digital Health Updates in the 2019 Physician Fee Schedule (PFS) Rule
  • Crowell & Moring LLP
  • USA
  • November 6 2018

CMS has finalized the adoption of multiple CPT codes in the CY 2019 PFS that create more opportunities for providers and digital health companies to


CMS considers linking Medicare drug payment rates to international prices
  • Hogan Lovells
  • USA
  • October 30 2018

On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an Advance Notice of Proposed Rulemaking (ANPRM) describing a potential


HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon
  • Arent Fox LLP
  • USA
  • October 29 2018

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or